Table: Wakamoto Pharm - Q1 parent results

Wakamoto Pharmaceutical

05/08/2026 07:33

    Aug 5 (Reuters)- 
             Wakamoto Pharmaceutical Co Ltd 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2026        Jun 30, 2025     Mar 31, 2027 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             2.43                2.17             11.00    
                 (+11.9 pct)         (+15.1 pct)      (+11.0 pct) 
  Operating     loss 136 mln        loss 143 mln        200 mln   
                                                      (-21.7 pct) 
  Recurring     loss 107 mln        loss 117 mln        200 mln   
                                                      (-22.0 pct) 
  Net               6 mln           loss 108 mln        230 mln   
                                                      (+1.2 pct)  
  EPS             0.19 yen          loss 3.12 yen      6.62 yen   
  Ann Div                             3.50 yen         3.50 yen   
  -Q2 div                                NIL              NIL     
  -Q4 div                             3.50 yen         3.50 yen   
  
  NOTE - Wakamoto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4512.T